Alzheimer's
disease progresses as specific nerve
cells in the brain, known as neurons,
increasingly die off. Evidence suggests
that in Alzheimer's, the brain is
under increased oxidative stress
and that this free radical attack
may be an underlying source of neuronal
damage.1
One specific type of free radical, lipid
peroxides, which can damage the fatty
layer of cell membranes, may play a key
role in accelerating the process of cell
aging in the brain.
A study
by Swedish and Finnish scientists found that Alzheimer's patients
produce more glutathione peroxidase, an enzyme that helps neutralize
free radicals, as a defensive reaction against increased production
of peroxides within the cells.2 Another
recent study found that Alzheimer's
patients with dementia often have "disturbance
in antioxidant balance which may predispose to increased oxidative
stress."3
Free
radical damage has also been closely linked to the formation of
plaque deposits in the brain, a hallmark of Alzheimer's disease.
When free radicals injure the cell membrane, they can impair the
cell's ability to regulate the passage of substances in and out
of the cell. As a result, cells can be damaged or even destroyed
by excess exposure to a normally healthy nutrient such as calcium.4
Numerous
experimental studies show that increased oxidative stress can impair
memory function in laboratory rodents.5-7 Clinical
trials on elderly human populations
also show that antioxidants are associated
with improved memory and learning performance.8-10 The
Alzheimer's Disease Cooperative Study,
a preliminary double-blind placebo-controlled
study of patients with moderate cases
of Alzheimer's disease, found that
supplementation with antioxidants (Vitamin
E or selegiline) could significantly
delay Alzheimer's-related complications.
Dementia and inability to perform daily
living tasks were, on the average,
25% slower to evolve in the patients
who received either of these antioxidant
supplements.11
Collectively,
this evidence suggests that assessing and reducing oxidative damage
may a beneficial clinical strategy to help prevent or retard the
development and progression of Alzheimer's disease.
The
Oxidative Stress Analysis (Blood and Urine) identifies urinary salicylate
markers of hydroxyl radical activity, urine lipid peroxides, glutathione
peroxidase, superoxide dismutase and reduced glutathione, revealing
the sources of potential cellular damage underlying age-associated
memory loss and Alzheimer's disease.
References:
1 Markesbery WR. Oxidative stress hypothesis in Alzheimer's disease.
Free Rad Biol Med 1997;23(1):134-147.
2 Anneren
G, Gardner A, Lundin T. Increased gluathione peroxidase activity
in erythrocytes in patients with Alzheimer's disease/senile dementia
of Alzheimer's type. Acta Neurol Scand 1986;73:586-589.
3 Sinclair
AJ, Bayer AJ, Johnston J, Warner C, Maxweel SR. Altered plasma antioxidant
status in subjects with Alzheimer's disease and vascular dementia.
Int J Geriatr Psychiatr 1998;13(120:840-5.
4 Mark
RJ, Lanc EM, Mattson MP. Amyloid beta-peptide and oxidative cellular
injury in Alzheimer's disease. Mol Neurobiol 1996;12(3):211-224.
5 Bruce-Keller
AJ, Li YJ, Lovell MA, Kraemer PJ, Gary DS, Grown RR, Markesbery
WR, Mattson MP.
4-hydroxynonenal, a produce of lipid peroxidation, damages cholinergic
neurons and impairs visuospatial memory in rats. J Neuropathol Exp
Neurol 1998;57(3):257-67.
6 Rivas-Arancibia
S, Vazquez-Sandoval R, Gonzalez-Kladiano D, Schneider-Rivas S, Lechuga-Guerrero
A. Effects of ozone exposure in rats on memory and levels of brain
and pulmonary superoxide dismutase. Environ Res 1998;76(1):33-9.
7 Shufitt-Hale
B, Erat SA, Joseph JA. Spatial learning and memory deficits induced
by dopamine administration with decreased glutathione. Free Radic
Biol Med 1998;24(7-8):1149-58.
8 Perrig
WJ, Perrig P, Stahelin HB. The relation between antioxidants and
memory performance in the old and very old. J Am Geriatr Soc 1997;45(6):718-24.
9 Perkins
AJ, Hendrie HC, Callahan CM, Gao S, Unversagt FW, Xu Y, Hall KS,
Hui SL. Association of antioxidants with memory in a multiethnic
elderly sample using the Third National Health and Nutrition Examination
Survey. Am J Epidemiol 1999;150(1):37-44.
10
Sinclair AJ, Bayer AJ, Johnston J, Warner C, Maxwell, SR. Altered
plasma antioxidant status in subjects with Alzheimer's disease and
vascular dementia. Int J Geriatr Psychiatry 1998;13(12):840-5.
11
Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M,
Woodbury P, Growdon J, Cotman CW, Pfeiffer E, Schneider LS, Thal
LJ. A controlled trial of selegiline, alpha-tocopherol, or both
as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative
Study. N Engl J Med 1997;336(17):1216-22.
Call
to set up a nutritional consultation
so that tests can be performed and
a comprehensive strategy of lifestyle,
dietary modification and nutrient supplementation
can be implemented to aid you in reversing
this disorder.
For an appointment, contact our office at: 800-956-7083 and visit our web site
www.completehealthinstitute.com go to lab tests and click on appropriate test
for information.
Dr. Rispoli, Ph.D., L Ac. has had a clinical practice for over 20 years. Her
programs work because she is so thorough in testing and providing a nutritional
approach. Remember that the body can heal itself if given the proper nutrients.
The information herein is not intended as diagnosis, treatment or a cure. Should
you have a medical condition please seek the advice of your medical doctor. |